What is the term given to a woman who has completed one pregnancy with a fetus or fetuses reaching the stage of fetal viability?

Emergency Department, Hospitalist, and Office Ultrasound (POCUS)

Grant C. Fowler MD, in Pfenninger and Fowler's Procedures for Primary Care, 2020

Evaluation of Fetal Viability

Detection of fetal heart activity by the second and third trimester of pregnancy should be reliable by transabdominal scanning (seeChapter 142, Obstetric Ultrasound). Earlier detection may require transvaginal scanning.

Interpretation

The absence of fetal cardiac activity and fetal movement after scanning for a 5-minute interval in a pregnancy of more than 20 weeks’ gestation is said to be 100% reliable for diagnosing a fetal demise. For a first-trimester pregnancy, if uncertainty exists about fetal heart activity, rescanning should be performed in 1 to 2 weeks.

Secondary criteria for fetal demise using POCUS include fetal anomalies such as hydrops, ascites, and pleural or pericardial effusions. Echogenic gas in the fetal heart and vessels may be early findings. Late findings include morphologic changes such as skeletal anomalies and unusual fetal positioning.

Reaction to external stimulation or uterine manipulation should cause brisk reflexes in viable fetuses, as opposed to the passive motions seen with a fetal demise. Avoid misinterpreting the passive motions from uterine contractions around a dead fetus as fetal activity.

Because abruptio placentae cannot always be diagnosed with ultrasound (i.e., it is a clinical diagnosis), ultrasound studies should be used in conjunction with maternal–fetal monitoring in the pregnant patient with significant abdominal trauma. A 4-hour monitoring period should be sufficient to identify fetal distress.

PATHOLOGY OF THE PLACENTA: AN INTRODUCTION AND OVERVIEW

Harold Fox MD FRCPath FRCOG, Neil J. Sebire MB BS BClinSci MD DRCOG MRCPath, in Pathology of the Placenta (Third Edition), 2007

Abnormal cardiotocograph (CTG)

Fetal wellbeing before and during labour is usually assessed by recording of the fetal heart rate in relation to uterine contractions in the form of a cardiotocograph tracing (CTG). There are well-established parameters indicating normality and abnormality according to gestational age (Gauge & Henderson 1999) and an ‘abnormal’ cardiotocographic pattern usually means either persistent fetal tachycardia or bradycardia, or abnormal decelerations following contractions in the form of persistent variable or late decelerations. These abnormal findings indicate abnormalities in the fetal cardiovascular response and may be associated with fetal hypoxia. In the context of pathological examination of the placenta, an ‘abnormal’ cardiotocograph should therefore prompt a search for features of underlying conditions likely to contribute to fetal hypoxia such as uteroplacental vascular disease; cord lesions and cord compression are also potent causes of fetal hypoxia and of abnormal tocographic traces. In many cases however, there is no underlying detectable morphological abnormality, the cardiotocographic features being a consequence of excessive stimulation of contractions in labour.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9781416025924500060

Obstetric Factors Associated with Infections of the Fetus and Newborn Infant

Christopher B. Wilson MD, in Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant, 2016

Preterm Premature Rupture of the Membranes Before Fetal Viability

The recommended approaches to PPROM before 23 to 24 weeks of gestation include labor induction or expectant management because the fetus is not yet viable. With expectant management for PROM before fetal viability, the latency period is relatively long (mean, 12-19 days; median, 6-7 days),281-285 although this may not achieve a gestational age consistent with neonatal survival. Neonatal survival depends on the gestational age at membrane rupture and duration of the latent period. In cases with PPROM at less than 23 weeks, the perinatal survival rate was 13% to 47%; with PPROM at 24 to 26 weeks, it was 50%. The incidence of stillbirth is greater (15%) with midtrimester PPROM than with later PPROM (1%). The incidence of lethal pulmonary hypoplasia is 50% to 60% when membrane rupture occurs before 19 weeks.286 Although maternal clinically evident infections are common (chorioamnionitis: 35%-59% and endometritis: 13%-17%) few of these infections are serious; however, maternal death from sepsis has been reported.283,285 If labor induction is chosen, after appropriate counseling, it can be facilitated by usual obstetric methods such as oxytocin or misoprostol administration.

Anthropology: Forensic Anthropology and Childhood

P. LefèvreF. BeauthierJ.-P. Beauthier, in Encyclopedia of Forensic and Legal Medicine (Second Edition), 2016

Infanticide and Death in the Neonatal Period

Viability of the Fetus

Fetal viability is a major issue that is dependent on the evolution and progress of modern neonatology (Beauthier, 2007). It is generally accepted that a 28-week-old fetus that doesn't need resuscitation is viable. However, according to WHO, fetal viability is possible after 20 weeks of fetal life (22 weeks of amenorrhea).Anthropometrical characteristics as well as clinical parameters of fetal age estimation are of high importance.

Determination of Fetal Age

A simple way to calculate fetal age (in lunar months) is to divide the fetal length (in cm) by 4 for fetuses less than 5 months' gestation. If it is less than 5 months' gestation the length (in cm) is divided by 5. Anthropometric measurements collected during examination of the fetus are used to estimate its age more accurately (Beauthier, 2011b). Three types of data can be gathered from radiologic investigations (Scheuer et al., 1980):

direct fetal age estimation from measurement of the length of long bones (Scheuer et al., 1980);

fetal age estimation from measurement of the long bones and calculation of fetal stature (crown–heel or crown–rump length) (O'Rahilly and Müller, 2001; Scheuer and Black, 2004); and

a more difficult method involving the degree of deciduous teeth calcification; this method requires the conservation of dental crowns and is not particularly suitable for this type of investigation.

Scheuer reports the following values from her study on full-term fetuses in the UK (Scheuer et al., 1980):

crown–rump length: from 28 to 32 cm; and

crown–heel length: from 48 to 52 cm.

Various authors have highlighted the importance of long bones radiography, in particular the fetal femoral diaphysis (Odita et al., 1982; Piercecchi-Marti et al., 2002). A study was carried out to investigate the fidelity and reproducibility of the radiographic methods used for measuring the femoral diaphysis (Adalian et al., 2001). The regression equation obtained was as follows:

Fetalage(inweeks)=6.93+0.434×femurlength(inmm)

The lower limb centers of ossification (distal epiphysis of the femur, proximal epiphysis of the tibia, posterior tarsus) are of great practical interest.

Echographic examination can provide useful information in the living subject.

Many studies have been carried out using ultrasonography, with a focus on the length of fetal long bones (Jeanty et al., 1984), the length of the femur, the relationship between the length of the femur and fetal weight (Honarvar et al., 2001), biparietal diameter, and cephalic and abdominal perimeters (Davis et al., 1993; Nasrat and Bondagji, 2005; Yagel et al., 1986). Using ultrasonography other authors have examined the relationship between fetal weight, abdominal perimeter, and femur length, and a mathematical model was proposed (Ferrero et al., 1994).

Table 2 shows some useful anthropometric and visceral parameters in the full-term fetus.

Table 2. Anthropometric and visceral parameters of the full-term fetus

ParametersFull-term fetus, statistics
Weight 3250–3500 g
Stature 50 (range 48–52) cm
Crown–rump length 28–32 cm
Maximum cranial perimeter (large cranial circumference) 37 cm
Minimum cranial perimeter (small cranial circumference) 33 cm
Biparietal diameter 9.5 cm
Bitemporal diameter 8 cm
Occipito-gnathion diameter 13 cm
Occipito-frontal diameter 11.5 cm
Suboccipito-frontal diameter 11 cm
Subgnathion-bregmatic vertical diameter 9.5 cm
Suboccipito-bregmatic diameter 9.5 cm
Abdominal perimeter (at umbilical) 30 cm
Transverse abdominal diameter 9.5 cm
Bitrochanteric diameter 9 cm
Length of long bones – average values in brackets (Fazekas and Kósa, 1978; Scheuer and Black, 2004)
Length of humerus 61.6–70 mm (64.9 mm)
Length of radius 47.5–58.0 mm (51.8 mm)
Length of ulna 55.0–65.5 mm (59.3 mm)
Length of femur 69.0–78.7 mm (74.3 mm)
Length of tibia 60.0–71.5 mm (65.1 mm)
Length of fibula 58.0–68.5 mm (62.3 mm)
Weight of left lung 25 g
Weight of right lung 30 g
Weight of heart 18 g
Weight of liver 100–125 g
Weight of spleen 9 g
Weight of brain 350 g
Centers (points) of ossification Full-term fetus (40 weeks)
Calcaneus (appearance: 27th week) (between 24th and 28th weeks) +
Talus (appearance: 28th week) +
Femur distal epiphysis (knee) (appearance: 37th week) +
Tibia proximal epiphysis (knee) (appearance: 40th week) +

Source: Beauthier, J-P., 2011a. La problématique du foetus et du nouveau-né en médecine légale. In: Beauthier, J-P. (Ed.), Traité de Médecine Légale. Bruxelles: De Boeck Université, pp. 389–402.

Signs Observed in the Stillborn Baby

Differentiating between the stillborn baby and the child who has not lived is not easy. The phenomena of maceration (aseptic autolysis which occurs when the fetus dies in utero) and putrefaction (postmortem ex utero deterioration) can notably complicate the medicolegal approach.

Descriptions of the criteria of extrauterine life are based on the existence of respiratory events and an effective circulatory system after birth. Cardiovascular function is evident in children who are victims of physical violence in particular (bruising, vital tegumentary lesions, associated fractures, and hemorrhage). Ventilatory function is assessed by histological study of the lung, and the presence or absence of territorial atelectasis is established. Multiple samples are required to clarify the matter.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780128000342000264

Obstetric Ultrasound : Imaging, Dating, Growth, and Anomaly

Mark B. Landon MD, in Gabbe's Obstetrics: Normal and Problem Pregnancies, 2021

M-Mode

For most obstetric applications, the familiar two-dimensional (2D) grayscale real-time ultrasound is used. This is formally known asB-mode ultrasound. Another ultrasound modality that is available on most machines is referred to asM-mode ultrasound (motion mode). M-mode ultrasound shows changes along a single ultrasound beam over time. M-mode is useful for documenting the presence and rate of fetal cardiac contractions (Fig. 9.3,eFig. 9.6) and is also used for specialized echocardiography applications, such as defining cardiac arrhythmias (eFig. 9.7).

eFig. 9.6. M-Mode Application in an 8-Week-Old Fetus.

The row of dots in theleft panel indicates the location of echoes, in this case cardiac pulsations, being displayed over time in theright panel. M-mode is preferred to Doppler for documenting fetal viability before 10 weeks. Note the prominent brain vesicle in the fetal head, a normal finding.

eFig. 9.7. M-Mode Ultrasound Demonstrating Premature Atrial Contractions.

The cursor line passes through the left ventricle(LV) then the right atrium(RA). The movement along the cursor line over time is shown in the lower display. Thered arrows show ventricular contractions, and thegreen arrows show atrial contractions. Note that when there is a premature atrial contraction(magenta arrow), the ventricle is in a refractory state, resulting in a pause between contractions.

Best Practice for Quantifying the Microscopic Structure of Mouse Placenta

Mariana M. Veras, ... Terry Mayhew, in The Guide to Investigation of Mouse Pregnancy, 2014

Overview

Fetal well-being depends on a satisfactorily functioning placenta. A proper understanding of the placenta requires an integrated approach that embraces all the biomedical disciplines including anatomy/morphology. As for other organs and tissues, information about three-dimensional (3D) structure is needed in order to better understand the processes by which the placenta develops, grows, and serves the needs of the embryo-fetus during normal and compromised pregnancies.1–6

Whether a quantitative or qualitative approach is adopted, methods for correlating structure and function need to be objective, precise (reliable, reproducible), unbiased or minimally biased (no or little systematic error), and efficient (giving a reasonable precision per unit of cost expressed as time, effort, or expense). The generation of hard (biologically useful) information about structure also raises issues of study design.

Biological structures exist and operate in 3D space, so valid interpretation of their functional relevance must recognize this fact. This is especially critical in the realms of optical and electron microscopy, where fine resolution of microstructure relies on cutting specimens into thin slices. In fact, the process of thin sectioning has several practical consequences. First, it limits the fraction of the specimen that can be examined; therefore, one needs to be confident that the fraction finally examined fairly reflects the whole. This implies that the sampling process itself is critical. Second, sectioning reduces 3D reality to a two-dimensional (2D) or planar representation. Thus, volumes appear on section planes as profile areas, surfaces appear as linear features (known as boundary traces), and linear structures (e.g., blood vessels) and particulate structures (e.g., cells and their nuclei) appear as transections or profiles. Therefore, there is a need for tools that allow researchers to extrapolate 3D quantities from those displayed on 2D images. Failure to recognize these consequences of sectioning will impair or frustrate the ability to draw hard biological interpretations.

Stereology7–10 provides valuable tools for obtaining functionally relevant 3D quantitative information at different levels of structural organization of biological specimens. Validity and efficiency are determined by designing random sampling methods at different stages of the hierarchical procedure for preparing specimens for microscopic examination.5,11 This includes selecting tissue blocks from the organ, cutting histological and other thin sections, and selecting microscopic fields of view (FOVs). Stereological tools have been applied successfully to placentas of different types, from mouse to human, and to investigate a variety of relevant processes, including placental growth and development, oxygen transport, fetoplacental angiogenesis, trophoblast turnover, immunogold-labeled protein localization, and the effects of maternal diet, environmental pollution, and pregnancy complications.1–6,12–23

In this chapter, we describe how to apply state-of-the-art stereology for basic morphofunctional analysis of the mouse placenta. Broadly speaking, stereological analysis involves a two-step process: (1) randomly sampling the organ/tissue/cell to generate sets of mechanical or optical sections and (2) sizing and/or counting structural features of interest on the sampled sections using appropriate geometric probes (test points, lines, planes or volumes).

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780123944450000461

Fetal Heart Failure

Edgar T. Jaeggi, Mary T. Donofrio, in Heart Failure in the Child and Young Adult, 2018

Prenatal Assessment

Introduction

Assessments of the fetal well-being and cardiac function and identification of a likely disease mechanism are important diagnostic steps in the clinical evaluation of the fetus with cardiac compromise. Table 28.1 summarizes the echocardiographic features of the main conditions associated with in-utero HF. The prenatal diagnosis of HF primarily relies on the ultrasound-based documentation of systolic and/or diastolic cardiac dysfunction and the circulatory consequences [31].

Table 28.1. Echocardiographic Features of Conditions Associated With Fetal Heart Failure

ConditionHypertrophyHeart SizeFunctionCardiac OutputOther Frequent Findings/Associations
DiastolicSystolic
Myocarditis•

Viral

Anti-Ro/SSA antibodies

N or ↑ N or ↓ Pericardial effusion
Anemia; ischemia; hypoalbuminemia
Myocardial echogenicity; CHB
Nonhypertrophic CM N or ↑ EFE; calcifications; NC; other anomalies
Hypertrophic CM Global N N Other anomalies
Diabetic hypertrophy IVS > free wall N N or ↓ N N Macrosomia
TTTS (recipient) RV > LV RV > LV RV > LV ↓ RV > LV Polyhydramnios
Vascular tumors; TRAP N Dilated systemic vein(s)
Agenesis of the DV N Dilated umbilical vein
Constriction of the DA ↑ RV ↓ RV ↓ RV ↓ RV Tricuspid regurgitation
Fetal anemia N ↑ peak MCA Doppler flow
Fetal hypoxemia ± acidosis N or ↓ N or ↓ N or ↓ Brain sparing
CCAM N or ↓ Chest mass
Large pericardial effusion N or ↓ Pericardial teratoma

CCAM, congenital cystic adenomatoid malformations of the lung; CHB, complete heart block; CM, cardiomyopathy; DA, ductus arteriosus; DV, ductus venosus; EFE, endocardial fibroelastosis; MCA, middle cerebral artery; N, normal; NC, ventricular noncompaction; RV > LV, right ventricle more severely affected than the left ventricle; TRAP, twin reversed arterial perfusion sequence; TTTS, twin–twin transfusion syndrome; ↑, increased; ↓, decreased; –, absent.

Measures of the Cardiovascular Status

In early stages of HF, disease manifestations that are readily detectable by echocardiography may be subtle. At more advanced stages (Fig. 28.1), findings include ascites, pleural effusion, pericardial effusion, or a combination of these findings, in addition to cardiomegaly, valvar regurgitation, poly- or oligohydramnios, preferential shunting of blood flow to the brain and heart, absence or reversal of the end-diastolic umbilical artery (UA) flow, and reduced or absent fetal movements. In end-stage HF, generalized skin edema is seen easily over the scalp and abdominal wall.

What is the term given to a woman who has completed one pregnancy with a fetus or fetuses reaching the stage of fetal viability?

Figure 28.1. Cardiac four-chamber view of a fetus diagnosed at 30 gestational weeks with a severe form of nonhypertrophic cardiomyopathy of unknown etiology. Findings included massive cardiomegaly, severe biventricular dilatation and dysfunction, and fetal hydrops.

Measures of Cardiac Function

M-mode is useful to quantify the fetal systolic ventricular function by measurements of the changes in ventricular dimensions at the end of diastole (EDD) and of systole (ESD), respectively. Ventricular shortening fraction is calculated as SF (%) = (EDD-ESD)/EDD × 100. An LV or RV SF <28% suggests impaired ventricular systolic function. A low SF is most commonly related to myocardial disease or high afterload [32] and is usually seen in association with other functional consequences such as diastolic dysfunction, cardiomegaly, and atrioventricular (AV) valvar regurgitation [33,34].

Measurement of the peak velocity (vmax) of the AV regurgitation jet, if present, is a geometry-independent indirect measure of the ventricular contractile force. The peak pressure a ventricle is able to generate in the setting of AV regurgitation is estimated as pressure = 4 × (vmax)2 + atrial pressure. A normal fetal atrial pressure is about 3–4 mmHg and a normal mid- to late-gestational AV valvar pressure gradient is typically in the range of 40–60 mmHg [29]. A lower pressure gradient in the setting of moderate/severe AV regurgitation and reduced/absent forward flow across the pulmonary or aortic valve indicates subnormal pressure-generating capacity of the related ventricle.

CO (mL/min/kg) is a crude estimate of the global cardiac function and can be calculated as CO = VTI × π × (D2/4) × HR/estimated fetal weight [35]. VTI relates to the velocity–time integral of the systolic aortic or pulmonary flow, D to the annulus diameter of the corresponding valve, and HR to the fetal heart rate. CO is not routinely measured but is useful to detect and monitor conditions associated with high-output failure such as AV malformations or vascular tumors [36–41].

Doppler flow profiles of the ventricular inflow, the systemic veins, and the DV provide crucial information on ventricular relaxation and compliance during diastole [42–44]. Normal fetal ventricular filling across the AV valves consists of three phases: (1) isovolumetric relaxation preceding ventricular inflow (IVR); (2) early passive filling (E-wave); and (3) late active filling during atrial contraction (A-wave). At a normal fetal heart rate, the duration of the IVR is <43 ms, and the Doppler inflow pattern is biphasic with a dominant A-wave as diastolic ventricular filling mainly results from atrial contraction [42,45]. Venous forward flow is initiated with the opening of the AV valves in early diastole, which causes an immediate drop in atrial pressure. Forward flow then slowly decreases with increasing ventricular pressure as the ventricles fill. With the onset of atrial contraction in late diastole there is a sudden increase in atrial pressure, which briefly slows the forward flow in the DV and briefly reverses the flow in the hepatic and caval veins away from the heart (a-waves). Doppler flows compatible with normal diastolic ventricular function include the following: (1) antegrade DV flow throughout the entire cardiac cycle; (2) a-wave flow reversal of <20 cm/s in the inferior vena cava; and (3) the absence of UV pulsations [46,47]. Biventricular diastolic dysfunction is very poorly tolerated by the fetus. The diagnosis of compromised diastolic filling is made on the detection of abnormal Doppler flows across the AV valves (monophasic, short inflow, or low E/A ratio; prolonged IVR interval), the DV (absent or reversed a-wave), and the inferior vena cava (a-wave reversal >20 cm/s) (Fig. 28.2). The presence of umbilical venous pulsations is a most useful predictor of imminent perinatal death in fetal hydrops.

What is the term given to a woman who has completed one pregnancy with a fetus or fetuses reaching the stage of fetal viability?

Figure 28.2. Atrioventricular (AV), inferior vena cava (IVC), venous duct (DV), and umbilical vein (UV) Doppler flow pattern in a fetus with progression from mild (A) to severe (B) diastolic dysfunction. (A) In mild diastolic dysfunction, the AV flow is still biphasic, while there is mildly increased reversal of flow in the IVC (>20 cm/s) and in the DV (to baseline) during atrial contraction (a-wave). The UV flow is nonpulsatile. (B) In severe diastolic dysfunction, the AV flow is monophasic and the inflow duration short. Related to the decreased relaxation and compliance and the increase in ventricular filling pressures, there is no early diastolic (D) forward flow in the IVC, a-wave reversal in DV, and pulsatile UV flow. a, late diastolic flow; D, early diastolic flow; S, systolic flow.

The myocardial performance index (MPI) is a combined measure of systolic and diastolic ventricular function and is calculated as the sum of the mitral or tricuspid isovolumetric relaxation and contraction times divided by the aortic or pulmonary ejection time, for the LV or RV, respectively. Doppler-derived MPI values above 0.48 are considered abnormal [48].

Heart Failure Score

The cardiovascular profile score (CVPS) is a composite scoring system that is used to grade the severity of fetal HF [49–51]. The score is based on the result of five ultrasound parameters that have been correlated with poor fetal outcome (Table 28.2): (1) cavity effusions; (2) venous Doppler; (3) cardiothoracic area ratio (CTR); (4) cardiac function; and (5) UA Doppler. Severity of HF is rated on a 10 point scale, and 1 or 2 points are deducted for abnormalities of each component marker. The degree of failure is graded as being absent (10 points), mild (8 or 9 points), moderate (6 or 7 points), or severe (<5 points). One point is deducted from the score at the detection of each of the following findings: (1) isolated effusion; (2) DV a-wave flow reversal; (3) CTR of 35%–50%; (4) holosystolic tricuspid regurgitation or SF <28%; and (5) absent end-diastolic UA flow. Two points are deducted with each of these findings: (1) skin edema; (2) pulsatile UV flow; (3) CTR >50%; (4) holosystolic mitral regurgitation or monophasic AV inflow; and (5) end-diastolic UA flow reversal.

Table 28.2. Cardiovascular Profile to Assess the Severity of Heart Failure Based on the Combined Result of Five Echocardiographic Variables. The Heart Failure Score is 10 if There Are no Abnormal Signs and Reflects Two Points for Each of Five Categories: Hydrops; Venous Doppler; Heart Size; Cardiac Function; and Arterial Doppler

Normal−1 Point−2 Points
Hydrops None (2 pts) Ascites or pleural effusion or pericardial effusion Skin edema
Venous Doppler (umbilical vein and ductus venosus)
UV

UV

DV (2 pts)

DV
UV pulsations
Heart size (heart area/chest area) >0.20 and <0.35 (2 pts) 0.35–0.50 >0.50 or <0.20
Cardiac function Normal TV and MV RV/LV SF >0.28 biphasic diastolic filling (2 pts) Holosystolic TR or RV/LV SF <0.28 Holosystolic MR or TR dP/dt 400 or monophasic filling
Arterial Doppler (umbilical artery)
UA (2 pts)

UA (AEDV)

UA (REDV)

AEDV, absent end-diastolic velocity; dP/dt, change in pressure over time of TR jet; DV, ductus venosus; LV, left ventricle; MR, mitral valve regurgitation; MV, mitral valve; pts, points; REDV, reversed end-diastolic velocity; RV, right ventricle; SF, ventricular shortening fraction; TR, tricuspid valve regurgitation; TV, tricuspid valve; UV, umbilical vein.

Using a modified CVPS from the original scoring system (replacement of “skin edema” with “fetal hydrops” and elimination of “tricuspid valve dP/dt” as 2-point criteria) in a study of fetal patients with primary forms of cardiomyopathy (CM), a lower score at the baseline exam was already significantly associated with mortality (hazard ratio: 1.45 per point decrease; 95% confidence interval: 1.16–1.79; P = .001) despite the potential of disease progression later in gestation or after birth: 1-year survival on diagnosis was 24% with a score ≤6 but 79% with a score of 7 or higher [51]. While this supports that the modified CVPS is a useful prognostic marker for fetal CM, it is important to recognize that its predictive value depends on the HF cause and whether treatment is available. For example, HF in an anemic fetus with acute parvovirus infection can be treated with blood transfusions and is expected to have a better outcome compared with a fetus with CM and the same low CVPS.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780128023938000284

Fetal Growth and Development

Karin M. Fuchs MD, in Fetal and Neonatal Secrets (Third Edition), 2014

Once IUGR is suspected, fetal well-being should be closely monitored with serial antenatal testing (biophysical profile ± non-stress test; Doppler studies); the frequency of testing will be influenced by the gestational age as well as the maternal and the fetal condition. The timing of delivery is based on fetal maturity, signs of fetal distress, or worsening maternal disease. §

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B978032309139800002X

The medical approach to labour

Suzanne Yates BA(Hons) DipHSEC MRSS(T) APNT PGCE(PCET), in Pregnancy and Childbirth, 2010

13.2 Monitoring in labour

Assessing fetal condition

Different checks are regularly made on the fetus to monitor how they are coping with labour. If it is deemed that the fetus is not coping, then interventions may be made either to speed up labour or deliver the fetus instrumentally.

Status of amniotic fluid

This provides some indication of fetal well-being. If there is thick meconium (fetal faecal excretion) at the onset of labour there is a five- to sevenfold increase in risk of perinatal death (MacDonald et al 1985) as well as morbidity resulting from the risk of meconium aspiration. The recent passage of meconium will be indicated by dark greenish-black-coloured amniotic fluid. Old or stale meconium is a paler greenish-brown. If there is fresh meconium the fetal heart is checked more frequently.

Pinard/manual monitoring

This is a hollow instrument (Pinard fetal stethoscope) placed on the woman's abdomen. It involves no ultrasound and is done intermittently. It is a traditional midwifery tool and often used in home births. Its accuracy depends on the skill of the individual caregiver. It is the least invasive form of fetal monitoring.

Electronic fetal monitoring

This can be hand held and intermittent or continuous.

An electronic fetal heart monitor or cardiotocograph (CTG), ultrasound, is placed over the woman's abdomen near the fetus's heart. It measures the fetal heart rate and gives a readout. It need not necessarily interfere with maternal position as the woman may still be able to utilise forward leaning or upright positions, although if she moves much the printout will be inaccurate. Some care providers prefer the woman to be semi-recumbent or side-lying. It cannot be used if the woman is in water.

Hand-held monitors, also called fetal Dopplers or sonicaids, which are not attached to a graphic record can be used. These can be used in the pool and the woman can remain more mobile than with the CTG.

The fetal heart rate is usually measured every 15–30 min in early labour and every 5 min in active labour. The normal rate is between 120 and 160 beats per minute.

Fetal scalp monitoring

This is done if more accurate monitoring is needed, which may be the case if there are risk factors present such as the use of oxytocin.

It involves inserting a spinal wire electrode through the cervix and attaching it to the fetal scalp. The heart rate is measured by calculating the intervals between R waves in the fetal electrocardiographic cycles. This method of monitoring is only possible when the waters have broken and if it is needed then the membranes need to be ruptured (ARM).

Fetal blood sampling (FBS)

When the fetal heart rate pattern is suspicious then FBS should be carried out (NICE 2001). The woman is placed in the left lateral position while a sample of blood is taken from the fetus's skull. This is sent for analysis and gives a more accurate indication of fetal distress than monitoring heart rate as it assesses oxygen levels in the brain.

Benefits

Monitoring in labour may enable the early detection of potential risks to fetal health.

Drawbacks

Continuous monitoring may interfere with the woman's ability to move and remain comfortable, thus increasing the need for pharmacological pain relief.

There is variation in the clinical interpretation of the data and altered heart rate does not necessarily mean fetal compromise.

Increased monitoring is associated with an increase in the rate of caesarean section, especially if it is used without fetal blood sampling.

Its increased use has not been linked with a decrease in maternal or fetal mortality or morbidity. Many clinicians believe that fetuses are just as safe if someone listens to the fetal heart just after a contraction has finished and in the interval between contractions with a Pinard stethoscope or hand-held Doppler machine.

No one fully understands the effects of ultrasound monitoring on the fetus although some small studies have postulated possible adverse effects (American Institute of Ultrasound in Medicine 2000).

Current NICE guidelines in the UK do not recommend continuous fetal monitoring in normal labour although many hospitals worldwide still employ it.

Bodywork implications

The client may need more support to get into comfortable positions.

The client may need emotional support as she may get worried about her baby.

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780702030550000133

Haywood L. Brown, in Obstetrics: Normal and Problem Pregnancies (Seventh Edition), 2017

Ultrasound

Ultrasound may be used to assess fetal well-being without exposing the fetus to ionizing radiation. Additionally, abdominal ultrasound may be a useful tool in the evaluation of the pregnant trauma victim for free intraperitoneal fluid, with reported sensitivity between 61% and 83% but specificity between 94% and 100%.54 Ultrasound is not particularly sensitive for detecting abruptio placentae, with reported identification in approximately 40% of cases. No clear guidelines have been established as to whether further imaging is necessary in the event of a negative ultrasound study in a hemodynamically stable patient. The Food and Drug Administration (FDA) has arbitrarily established a safe upper limit for energy exposure during ultrasonography at 94 mW/cm.2,55

Read full chapter

URL: https://www.sciencedirect.com/science/article/pii/B9780323321082000263